1. ICAAS, Summary of animal safety studies with amino acids.
2. Bowery, N. and Smart, T., GABA and glycine as neurotransmitters: a brief history. British journal of pharmacology, 2006. 147(S1).
3. Japan Food Chemical Research Foundation, List of Designated Additives. 2016.
4. Kawai, N., Sakai, N., Okuro, M., Karakawa, S., Tsuneyoshi, Y., Kawasaki, N., Takeda, T., Bannai, M., and Nishino, S., The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus. Neuropsychopharmacology, 2015. 40(6): 1405.
5. Bannai, M. and Kawai, N., New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Journal of pharmacological sciences, 2012. 118(2): 145- 148.
6. Joint FAO/WHO Expert Committee on Food Additives, Summary of Evaluations performed by the Joint FAO/WHO Expert Committee on Food Additives: GLYCINE. 2004.
7. EFSA, SCIENTIFIC OPINION Flavouring Group Evaluation 79, (FGE.79). Consideration of amino acids and related substances evaluated by JECFA (63rd meeting) structurally related to amino acids from chemical group 34 evaluated by EFSA in FGE. The EFSA Journal, 2008. 870: 1-46.
8. Anderson, S.A. and Raiten, D.J., Safety of amino acids used as dietary supplements. 1992.
9. The Physical and Theoretical Chemistry Laboratory, Oxford University, Safety data for glycine (MSDS). 2005.
10. Kitahori, Y., Konishi, N., Hayashi, I., Nakahashi, K., Kitamura, M., Nakamura, Y., Matsuda, H., Fukushima, Y., Yoshioka, N., and Hiasa, Y., Carcinogenicity study of glycine in Fischer 344 rats. Journal of Toxicologic Pathology, 1994. 7(4): 471-480.
11. MHLW, Partial Revision of Guidelines for Repeated-dose Toxicity Studies. Notification No. 655 of the Pharmaceutical and Medical Safety Bureau. 1999.
12. Snedecor, G. and Cochran, W., Analysis of variance: the random effects model. Statistical Methods. Iowa State University Press, Ames, IA, 1989: 237-252.
13. Dunnett, C.W., A multiple comparison procedure for comparing several treatments with a control. Journal of the American Statistical Association, 1955. 50(272): 1096- 1121.
14. Steel, R.G., A multiple comparison rank sum test: treatments versus control. Biometrics, 1959: 560-572.
15. Sabelli, H.C., Fawcett, J., Gusovsky, F., Javaid, J., Wynn, P., Edwards, J., Jeffriess, H., and Kravitz, H., Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplements. The Journal of clinical psychiatry, 1986. 47(2): 66-70.
16. Giardina, W.J., Analgesic properties of phenylethylamine and phenylethanolamine in mice. Pharmacology, 1974. 12(1): 1-6.
17. Butchko, H.H., Stargel, W.W., Comer, C.P., Mayhew, D.A., Benninger, C., Blackburn, G.L., de Sonneville, L.M., Geha, R.S., Hertelendy, Z., and Koestner, A., Aspartame: review of safety. Regulatory Toxicology and Pharmacology, 2002. 35(2): S1-S93.
18. Muramatsu, K., Odagiri, H., Morishita, S., and Takeuchi, H., Effect of excess levels of individual amino acids on growth of rats fed casein diets. Journal of Nutrition, 1971. 101(9): 1117-1125.
19. Gibbs, J., Falasco, J.D., and McHugh, P.R., Cholecystokinin-decreased food intake in rhesus monkeys. American Journal of Physiology--Legacy Content, 1976. 230(1): 15- 18.
20. OECD, OECD Guidelines for the Testing of Chemicals, Section 4, Test No. 407, Repeated Dose 28-day Oral Toxicity Study in Rodents. 2008.
21. Peng, Y., Gubin, J., Harper, A., Vavich, M., and Kemmerer, A., Food intake regulation: amino acid toxicity and changes in rat brain and plasma amino acids. The Journal of nutrition, 1973. 103(4): 608-617.
22. Solms, J., Taste of amino acids, peptides, and proteins. Journal of Agricultural and Food Chemistry, 1969. 17(4): 686-688.
23. Nagaoka, S., Masaki, H., Aoyama, Y., and Yoshida, A., Effects of excess dietary tyrosine or certain xenobiotics on the cholesterogenesis in rats. The Journal of nutrition, 1986. 116(5): 726-732.
24. Muramatsu, K., Arito, T., and Tsuda, H., Effect of individual amino acid supplements on the toxicity of excess tyrosine in rats. Journal of nutritional science and vitaminology, 1976. 22(5): 397-403.
25. Alam, S., Becker, R., Stucki, W., Rogers, Q., and Harper, A., Effect of threonine on the toxicity of excess tyrosine and cataract formation in the rat. The journal of nutrition, 1966. 89(1): 91-96.
26. Baldrick, P., Richardson, D., and Wheeler, A.W., Review of L‐tyrosine confirming its safe human use as an adjuvant. Journal of Applied Toxicology, 2002. 22(5): 333-344.
27. MHLW, Guidelines for Designation of Food Additives and for Revision of Standards for Use of Food Additives., Notification No. 29 of the Environmental Health Bureau. 1996.
28. OECD, OECD Guidelines for the Testing of Chemicals, Section 4, Test No. 408, Repeated Dose 90‐Day Oral Toxicity Study in Rodents. 1998.
29. MHLW, The Ordinance on Standard for Conduct of Non‐Clinical Studies on Safety of Drugs., Ordinance No. 21 of the Ministry of Health and Welfare. 1997.
30. EFSA, Scientific opinion flavouring group evaluation 79, (FGE.79). consideration of amino acids and related substances evaluated by JECFA (63rd meeting) structurally related to amino acids from chemical group 34 evaluated by EFSA in FGE. EFSA Journal, 2008. 26(870): 1-46.
31. Blokland, A., Lieben, C., and Deutz, N.E., Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. Journal of Psychopharmacology, 2002. 16(1): 39-49.
32. Austin, G.L., Ogden, L.G., and Hill, J.O., Trends in carbohydrate, fat, and protein intakes and association with energy intake in normal-weight, overweight, and obese individuals: 1971–2006. The American journal of clinical nutrition, 2011. 93(4): 836-843.
33. Fernstrom, J.D., A perspective on the safety of supplemental tryptophan based on its metabolic fates. The Journal of nutrition, 2016. 146(12): 2601S-2608S.
34. Trumbo, P., Schlicker, S., Yates, A.A., and Poos, M., Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. Journal of the American Dietetic Association, 2002. 102(11): 1621-1630.
35. WHO/FAO/UNU, Protein and amino acid requirements in human nutrition. Vol. 935. 2007: World Health Organization.
36. Okuno, A., Fukuwatari, T., and Shibata, K., Urinary excretory ratio of anthranilic acid/kynurenic acid as an index of the tolerable amount of tryptophan. Bioscience, biotechnology, and biochemistry, 2008. 72(7): 1667-1672.
37. Meltzer, H.Y., Role of serotonin in depression. Annals of the New York Academy of Sciences, 1990. 600(1): 486-499.
38. Jouvet, M., Biogenic amines and the states of sleep. Science, 1969. 163(3862): 32-41.
39. Fernstrom, J.D., Effects and side effects associated with the non-nutritional use of tryptophan by humans. The Journal of nutrition, 2012: 2236S-2244S.
40. Kawaguchi, Y., Hayashi, S., Takemoto, Y., and Kotera, K., Toxicological studies on N- acetyl-L-tryptophan IX chronic toxicity in rats. Iyakuhin Kenkyu, 1980. 12(1): 129- 143.
41. Kotera, K., Kawaguchi, Y., and Takemoto, Y., Toxicological studies on N-acetyl-L- tryptophan X chronic toxicity in rabbits. Iyakuhin Kenkyu, 1980. 12(1): 144-162.
42. Mawatari, K.-i., Oshida, K., Iinuma, F., and Watanabe, M., Determination of quinolinic acid in human urine by liquid chromatography with fluorimetric detection. Analytica chimica acta, 1995. 302(2-3): 179-183.
43. Shibata, K., Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 1988. 430: 376-380.
44. Shibata, K. and Onodera, M., Simultaneous high-performance liquid chromatographic measurement of xanthurenic acid and 3-hydroxyanthranilic acid in urine. Bioscience, biotechnology, and biochemistry, 1992. 56(6): 974-974.
45. Ayaso, R., Ghattas, H., Abiad, M., and Obeid, O., Meal pattern of male rats maintained on amino acid supplemented diets: The effect of tryptophan, lysine, arginine, proline and threonine. Nutrients, 2014. 6(7): 2509-2522.
46. Voigt, J.-P. and Fink, H., Serotonin controlling feeding and satiety. Behavioural brain research, 2015. 277: 14-31.
47. Coşkun, Ş., Özer, Ç., Gönül, B., Take, G., and Erdoğan, D., The effect of repeated tryptophan administration on body weight, food intake, brain lipid peroxidation and serotonin immunoreactivity in mice. Molecular and cellular biochemistry, 2006. 286(1-2): 133-138.
48. Blundell, J.E., Serotonin manipulations and the structure of feeding behaviour. Appetite, 1986. 7: 39-56.
49. Chouinard, G., Young, S., Annable, L., and Sourkes, T., Tryptophan‐nicotinamide, imipramine and their combination in depression. Acta Psychiatrica Scandinavica, 1979. 59(4): 395-414.
50. Schwarcz, R., Whetsell, W.O., and Mangano, R.M., Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science, 1983. 219(4582): 316-318.
51. During, M.J., Freese, A., Heyes, M.P., Swartz, K.J., Markey, S.P., Roth, R.H., and Martin, J.B., Neuroactive metabolises of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid effect of tryptophan loading. FEBS letters, 1989. 247(2): 438-444.
52. Hertzman, P.A., Blevins, W.L., Mayer, J., Greenfield, B., Ting, M., and Gleich, G.J., Association of the eosinophilia–myalgia syndrome with the ingestion of tryptophan. New England journal of medicine, 1990. 322(13): 869-873.
53. Kaufman, L.D. and Philen, R.M., Tryptophan. Drug safety, 1993. 8(2): 89-98.
54. Toyo'oka, T., Yamazaki, T., Tanimoto, T., Sato, K., Sato, M., Toyoda, M., Ishibashi, M., Yoshihara, K., and Uchiyama, M., Characterization of contaminants in EMS- associated L-tryptophan samples by high-performance liquid chromatography. Chemical and pharmaceutical bulletin, 1991. 39(3): 820-822.
55. Crofford, L., Rader, J., Dalakas, M., Hill Jr, R., Page, S., Needham, L., Brady, L., Heyes, M., Wilder, R., and Gold, P., L-tryptophan implicated in human eosinophilia- myalgia syndrome causes fasciitis and perimyositis in the Lewis rat. Journal of Clinical Investigation, 1990. 86(5): 1757-1763.
56. Taylor, M. and Richardson, T., Antioxidant activity of cysteine and protein sulfhydryls in a linoleate emulsion oxidized by hemoglobin. Journal of Food Science, 1980. 45(5): 1223-1227.
57. Ahmed, E.A., Omar, H.M., Ragb, S.M., and Nasser, A.Y., The antioxidant activity of vitamin C, DPPD and L-cysteine against cisplatin-induced testicular oxidative damage in rats. Food and Chemical Toxicology, 2011. 49(5): 1115-1121.
58. Oser, B. and Hall, R., Recent progress in the consideration of flavoring ingredients under the food additives amendment. 5. GRAS substances. Food technology, 1972.
59. FDA, Code of Federal Regulations Title 21. 1. B. Food for Human Consumption (Continued). 184. Direct Food Substances Affirmed as Generally Recognized as Safe.
60. FDA, Code of Federal Regulations Title 21. 1. B. Food for Human Consumption (Continued). 172. Food Additives Permitted for Direct Addition to Food for Human Consumption.
61. Csapó, J., Albert, C., and Csapó-Kiss, Z., The D-amino acid content of foodstuffs (a review). Acta Univ Sapientiae, Aliment, 2009. 1: 5-30.
62. Man, E.H. and Bada, J.L., Dietary D-amino acids. Annual review of nutrition, 1987. 7(1): 209-225.
63. Sawamoto, O., Kyo, S., Kaneda, S., Harada, M., Kishimoto, S., Koshitani, O., Kurisu, K., and Nakashima, Y., Four-week intravenous repeated dose toxicity study of L- cysteine in male rats. The Journal of toxicological sciences, 2003. 28(2): 95-107.
64. Kitahori, Y., Konishi, N., Nakagawa, Y., Cho, M., Naitoh, H., Yamamoto, K., Matsui, E., and Hiasa, Y., Lack of carcinogenicity of L-cysteine monohydrochloride in Fischer 344 rats. Journal of Toxicologic Pathology, 1997. 10(2): 83-89.
65. Friedman, M. and Levin, C.E., Nutritional and medicinal aspects of D-amino acids. Amino acids, 2012. 42(5): 1553-1582.
66. Smith, S.W., Chiral toxicology: it's the same thing… only different. Toxicological sciences, 2009. 110(1): 4-30.
67. Shibuya, N., Koike, S., Tanaka, M., Ishigami-Yuasa, M., Kimura, Y., Ogasawara, Y., Fukui, K., Nagahara, N., and Kimura, H., A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells. Nature communications, 2013. 4: 1366.
68. Frazier, K.S., Seely, J.C., Hard, G.C., Betton, G., Burnett, R., Nakatsuji, S., Nishikawa, A., Durchfeld-Meyer, B., and Bube, A., Proliferative and nonproliferative lesions of the rat and mouse urinary system. Toxicologic Pathology, 2012. 40(4_suppl): 14S-86S.
69. Yin, J., Ren, W., Yang, G., Duan, J., Huang, X., Fang, R., Li, C., Li, T., Yin, Y., and Hou, Y., l‐Cysteine metabolism and its nutritional implications. Molecular nutrition & food research, 2016. 60(1): 134-146.
70. Krijgsheld, K.R., Glazenburg, E.J., Scholtens, E., and Mulder, G.J., The oxidation of L-and D-cysteine to inorganic sulfate and taurine in the rat. Biochimica et Biophysica Acta (BBA)-General Subjects, 1981. 677(1): 7-12.
71. Stipanuk, M.H., Metabolism of sulfur-containing amino acids. Annual review of nutrition, 1986. 6(1): 179-209.
72. Sawamoto, O., Yamate, J., Kuwamura, M., Kotani, T., and Kurisu, K., Development of sperm granulomas in the epididymides of L-cysteine-treated rats. Toxicologic pathology, 2003. 31(3): 281-289.
73. Sawamoto, O., Kurisu, K., Kuwamura, M., Kotani, T., and Yamate, J., Relationship of interstitial edema with L-cysteine-induced sperm granulomas in the pubertal rat epididymis. Experimental and Toxicologic Pathology, 2003. 55(2-3): 121-127.
74. Snary, D., Allen, A., and Pain, R., Structural studies on gastric mucoproteins: lowering of molecular weight after reduction with 2-mercaptoethanol. Biochemical and biophysical research communications, 1970. 40(4): 844-851.
75. Sheffner, A., THE REDUCTION IN VITRO IN VISCOSITY OF MUCOPROTEIN SOLUTIONS BY A NEW MUCOLYTIC AGENT, N‐ ACETYL‐ L‐ CYSTEINE. Annals of the New York Academy of Sciences, 1963. 106(1): 298-310.
76. Ji, Y., Wu, Z., Dai, Z., Sun, K., Zhang, Q., and Wu, G., Excessive l-cysteine induces vacuole-like cell death by activating endoplasmic reticulum stress and mitogen- activated protein kinase signaling in intestinal porcine epithelial cells. Amino acids, 2016. 48(1): 149-156.
77. McGavigan, A.K., O'Hara, H.C., Amin, A., Kinsey-Jones, J., Spreckley, E., Alamshah, A., Agahi, A., Banks, K., France, R., and Hyberg, G., L-cysteine suppresses ghrelin and reduces appetite in rodents and humans. International Journal of Obesity, 2015. 39(3): 447-455.
78. Lee, S., Han, K.-H., Nakamura, Y., Kawakami, S., Shimada, K.-i., Hayakawa, T., Onoue, H., and Fukushima, M., Dietary L-cysteine improves the antioxidative potential and lipid metabolism in rats fed a normal diet. Bioscience, biotechnology, and biochemistry, 2013. 77(7): 1430-1434.
79. Huang, J., Khan, S., and O’Brien, P.J., The glutathione dependence of inorganic sulfate formation from L-or D-cysteine in isolated rat hepatocytes. Chemico-biological interactions, 1998. 110(3): 189-202.
80. FDA, Guidance for industry and other stakeholders, Toxicological principles for the safety assessment of food ingredients. Redbook 2000, 2007.
81. EFSA, Guidance for submission for food additive evaluations. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). 2012.
82. Lehman AJ, F.O., 100-Fold margin of safety. Assoc. Food Drug Off. Quart. Bull, 1954. 18: 33-35.
83. Medicine, I.o., Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. . Food and Nutrition board. Washington, DC: National Academy Press, 2002.
84. Zu, K., Pizzurro, D., Lewandowski, T., and Goodman, J., Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts. Regulatory Toxicology and Pharmacology, 2017. 89: 83-94.
85. Sakai, R., Miura, M., Amao, M., Kodama, R., Toue, S., Noguchi, Y., and Kimura, T., Potential approaches to the assessment of amino acid adequacy in rats: a progress report. The Journal of nutrition, 2004. 134(6): 1651S-1655S.